Thermo Fisher buys Solventum’s purification and filtration business for $4.1 billion
(Reuters) -Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum’s purification and filtration business for about $4.1 billion, sending the latter’s shares up around 9%. The deal should allow Thermo to enter the filtration category in bioprocessing, where peers Danaher and Repligen are more strongly positioned, said Leerink Partners analyst Puneet…
